Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 53.53

+4.5%

Nov 25 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (1121)	5/18/2000 11:24:00 PM
From: Jim Oravetz	Read Replies (1) of 52153

FUND VIEW-Biotech valuations to triple over three years By Nick Edwards HONG KONG, May 18 (Reuters) - Nasdaq-listed biotechnology shares could see valuations triple over the next three years as U.S. federal drug approvals and the coveted patents that go with them begin to be awarded, a senior fund manager said on Thursday. snip.... biz.yahoo.com No specific companies mentioned, but some general stat's on drugs in development. Jim

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next